Satellite Symposia at the 2024 Oncology Nursing Society Congress
April 24-27, 2024
April 24-27, 2024
Benjamin Tomlinson, MD, discusses the first-line approval of luspatercept and other ongoing research in low-risk MDS.
Oncology Times reports essential clinical news for oncologists, hematologists and other cancer care
Katherine Wang, MD, discusses the role of active surveillance for patients with renal masses and the ongoing MUSIC-KIDNEY project in Michigan.
An abstract is unavailable.
Assisting Healthcare Providers with Expanded Access Requests for Investigational Oncology Products
Addiction researcher Francesco Versace, Ph.D., studies how the brain responds to nicotine. Here, he answers some common questions about vaping and how it impacts brain…
Drs Merkow and Connell discuss the use of HAI therapy for patients with colorectal cancer.
The novel EHA/EBMT grading of ICAHT closely reflects the extent of hematological toxicity following BCMA- and CD19-directed CAR-T therapy.Severe ICAHT was
Joshua J. Meeks, MD, PhD, discusses effectively implementing recent therapeutic advances across the disease continuum of bladder cancer.
In a Chinese study, investigators found that sequential CD7 CAR T-cell therapy and allogeneic hematopoietic stem cell transplantation (HSCT) without graft-vs-host disease (GVHD) prophylaxis was…